At the same time, the level of PD-L1 in lung and distant metastatic tissues is positively correlated with clinical benefit, but the level of PD-L1 in lymph node metastasis may not be correlated with clinical benefit. Here, CD274 is linked to metastatic malignant neoplasm in the lymph nodes.